Kahn SE, Cooper ME, Prato SD. Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future. Lancet. 2014;383(9922):1068–83. https://doi.org/10.1016/s0140-6736(13)62154-6.

Article  CAS  PubMed  Google Scholar 

Sun H, et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119. https://doi.org/10.1016/j.diabres.2021.109119.

Article  PubMed  Google Scholar 

Chan JCN, et al. The Lancet Commission on diabetes: using data to transform diabetes care and patient lives. Lancet. 2020;396(10267):2019–82. https://doi.org/10.1016/s0140-6736(20)32374-6.

Article  CAS  PubMed  Google Scholar 

Seshasai SRK, et al. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med. 2011;364(9):829–41. https://doi.org/10.1056/nejmoa1008862.

Article  CAS  Google Scholar 

Sandoval DA, Patti ME. Glucose metabolism after bariatric surgery: implications for T2DM remission and hypoglycaemia. Nat Rev Endocrinol. 2022; https://doi.org/10.1038/s41574-022-00757-5.

Article  PubMed  PubMed Central  Google Scholar 

Schauer PR, et al. Bariatric surgery versus intensive medical therapy for diabetes—5-year outcomes. N Engl J Med. 2017;376(7):641–51. https://doi.org/10.1056/nejmoa1600869.

Article  PubMed  PubMed Central  Google Scholar 

Mingrone G, et al. Metabolic surgery versus conventional medical therapy in patients with type 2 diabetes: 10-year follow-up of an open-label, single-centre, randomised controlled trial. Lancet. 2021;397(10271):293–304. https://doi.org/10.1016/s0140-6736(20)32649-0.

Article  PubMed  Google Scholar 

Ikramuddin S, et al. Lifestyle intervention and medical management with vs without Roux-en‑Y gastric bypass and control of hemoglobin A1C, LDL cholesterol, and systolic blood pressure at 5 years in the diabetes surgery study. JAMA. 2018;319(3):266–78. https://doi.org/10.1001/jama.2017.20813.

Article  PubMed  PubMed Central  Google Scholar 

Coleman KJ, et al. Long-term microvascular disease outcomes in patients with type 2 diabetes after Bariatric surgery: evidence for the legacy effect of surgery. Diabetes Care. 2016;39(8):1400–7. https://doi.org/10.2337/dc16-0194.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aminian A, et al. Association of metabolic surgery with major adverse cardiovascular outcomes in patients with type 2 diabetes and obesity. JAMA. 2019;322(13):1271–82. https://doi.org/10.1001/jama.2019.14231.

Article  PubMed  PubMed Central  Google Scholar 

O’Brien R, et al. Microvascular outcomes in patients with diabetes after Bariatric surgery versus usual care: a matched cohort study. Ann Intern Med. 2018;169(5):300–10. https://doi.org/10.7326/m17-2383.

Article  PubMed  PubMed Central  Google Scholar 

Syn NL, et al. Association of metabolic-bariatric surgery with long-term survival in adults with and without diabetes: a one-stage meta-analysis of matched cohort and prospective controlled studies with 174 772 participants. Lancet. 2021;397(10287):1830–41. https://doi.org/10.1016/s0140-6736(21)00591-2.

Article  PubMed  Google Scholar 

Rubino F, et al. Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by international diabetes organizations. Diabetes Care. 2016;39(6):861–77. https://doi.org/10.2337/dc16-0236.

Article  CAS  PubMed  Google Scholar 

A. D. A. P. P. Committee, et al. 8. Obesity and weight management for the prevention and treatment of type 2 diabetes: standards of medical care in diabetes—2022. Diabetes Care. 2021;45(Supplement_1):S113–S24. https://doi.org/10.2337/dc22-s008.

Article  Google Scholar 

Salminen P, et al. Effect of laparoscopic sleeve gastrectomy vs Roux-en‑Y gastric bypass on weight loss, comorbidities, and reflux at 10 years in adult patients with obesity. JAMA. 2022;157(8):656–66. https://doi.org/10.1001/jamasurg.2022.2229.

Article  Google Scholar 

Peterli R, et al. Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en‑Y gastric bypass on weight loss in patients with morbid obesity: the SM-BOSS randomized clinical trial. JAMA. 2018;319(3):255–65. https://doi.org/10.1001/jama.2017.20897.

Article  PubMed  PubMed Central  Google Scholar 

Laurenius A, et al. Resolution of diabetes, gastrointestinal symptoms, and self-reported dietary intake after gastric bypass versus sleeve gastrectomy: a randomized study. Surg Obes Relat Dis. 2023;19(5):440–8. https://doi.org/10.1016/j.soard.2022.10.019.

Article  PubMed  Google Scholar 

McTigue KM, et al. Comparing the 5‑year diabetes outcomes of sleeve gastrectomy and gastric bypass. JAMA Surg. 2020;155(5):e200087. https://doi.org/10.1001/jamasurg.2020.0087.

Article  PubMed  PubMed Central  Google Scholar 

Howard R, et al. Medication use for obesity-related comorbidities after sleeve gastrectomy or gastric bypass. JAMA Surg. 2022;157(3):248–56. https://doi.org/10.1001/jamasurg.2021.6898.

Article  PubMed  PubMed Central  Google Scholar 

Lewis KH, et al. Comparative effectiveness of vertical sleeve gastrectomy versus roux-en‑Y gastric bypass for diabetes treatment. Ann Surg. 2021;273(5):940–8. https://doi.org/10.1097/sla.0000000000003391.

Article  PubMed  Google Scholar 

McGlone ER, et al. Bariatric surgery for patients with type 2 diabetes mellitus requiring insulin: Clinical outcome and cost-effectiveness analyses. PLoS Med. 2020;17(12):e1003228. https://doi.org/10.1371/journal.pmed.1003228.

Article  PubMed  PubMed Central  Google Scholar 

Lemus R, Karni D, Hong D, Gmora S, Breau R, Anvari M. The impact of bariatric surgery on insulin-treated type 2 diabetes patients. Surg Endosc. 2018;32(2):990–1001. https://doi.org/10.1007/s00464-017-5777-5.

Article  PubMed  Google Scholar 

Alkharaiji M, Anyanwagu U, Donnelly R, Idris I. Effect of bariatric surgery on cardiovascular events and metabolic outcomes in obese patients with insulin-treated type 2 diabetes: a retrospective cohort study. Obes Surg. 2019;29(10):3154–64. https://doi.org/10.1007/s11695-019-03809-4.

Article  PubMed  Google Scholar 

Currie CJ, Poole CD, Evans M, Peters JR, Morgan CL. Mortality and other important diabetes-related outcomes with insulin vs other antihyperglycemic therapies in type 2 diabetes. J Clin Endocrinol Metab. 2013;98(2):668–77. https://doi.org/10.1210/jc.2012-3042.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Roumie CL, et al. Association between intensification of metformin treatment with insulin vs sulfonylureas and cardiovascular events and all-cause mortality among patients with diabetes. JAMA. 2014;311(22):2288–96. https://doi.org/10.1001/jama.2014.4312.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pucci A, et al. Type 2 diabetes remission 2 years post Roux-en‑Y gastric bypass and sleeve gastrectomy: the role of the weight loss and comparison of DiaRem and DiaBetter scores. Diabet Med. 2018;35(3):360–7. https://doi.org/10.1111/dme.13532.

Article  CAS  PubMed  Google Scholar 

Still CD, Benotti P, Mirshahi T, Cook A, Wood GC. DiaRem2: Incorporating duration of diabetes to improve prediction of diabetes remission after metabolic surgery. Surg Obes Relat Dis. 2019;15(5):717–24. https://doi.org/10.1016/j.soard.2018.12.020.

Article  PubMed  Google Scholar 

Aron-Wisnewsky J, et al. The advanced-DiaRem score improves prediction of diabetes remission 1 year post-Roux-en‑Y gastric bypass. Diabetologia. 2017;60(10):1892–902. https://doi.org/10.1007/s00125-017-4371-7.

Article  PubMed  Google Scholar 

Aminian A, et al. Individualized metabolic surgery score. Ann Surg. 2017;266(4):650–7. https://doi.org/10.1097/sla.0000000000002407.

Article  PubMed  Google Scholar 

Aminian A, et al. Late relapse of diabetes after Bariatric surgery: not rare, but not